Systemic sclerosis patients with unhealed digital ulcers benefit from fat cell transplant

February 25, 2015

Putnam Valley, NY. (Feb. 25, 2015) - Digital ulcers (DUs) are a frequent, painful, and quality of life altering complication for patients with systemic sclerosis (SSc), a connective tissue disease causing a progressive loss of small blood vessels and resulting changes in organs and tissues. DUs on the fingertips of SSc patients are slow to heal, if they heal at all, as many are unresponsive to any therapies.

However, a team of researchers in Italy has found that local implants of autologous (self-donated) adipose (fat) tissue-derived cells (ATDCs) resulted in significant pain reduction and healing within two to seven weeks post-transplantation for all 15 patients with long-lasting, non-healing DUs who enrolled in their study.

Study results, to be published in a future issue of Cell Transplantation, are currently freely available on-line as an unedited early e-pub at: http://ingentaconnect.com/content/cog/ct/pre-prints/content-CT-1325_Del_Papa_et_al

"DU healing and significant improvement in DU-related pain in all of the patients in the study can certainly be regarded as extremely positive," said study co-author Dr. Nicoletta Del Papa of the U.O.C. Day Hospital Reumatolgia in Milan, Italy. "However, why the local implantation of ATDC fraction-containing ASCs along with a stromal/vascular cell (SV) component induced such positive changes in the DUs of patients with SSc remains speculative."

The researchers suggested that, as demonstrated in several in vitro and in vivo studies, locally implanted ASCs are capable of producing a number of growth factors with pro-angiogenic (blood vessel growing) and proliferation-inducing factors, such as endothelial growth factor and fibroblast growth factor. Also, the SV component likely played a role in the positive outcomes.

"Recent data shows higher angiogenic potential of freshly isolated ATDCs when the SV fraction component is included as opposed to when the SV fraction is reduced," explained Dr. Del Papa.

The researchers also noted that ATDCs are "an attractive alternative" to using bone marrow-derived mesenchymal stem cells (BMSCs) in the procedure because ATDCs are more easily isolated, are more abundant, and are more rapidly expanded than BMSCs.

"Our study suggests that autologous transplantation of the ATDC fraction may be a viable option for inducing improvement or healing in ischemic, SSc-related DUs that are resistant to traditional therapeutic approaches," concluded the researchers. "While the positive outcomes need to be confirmed in larger, controlled studies, our favorable outcome suggests that the local grafting with ATDCs could represent a promising option for the treatment of SSc-related DUs."

"ATDC transplantation including the stromal vascular fraction led to more complete recovery in patients with digital ulcers," says Maria Carolina Oliveira Rodrigues of the Ribeirão Preto Medical School - University of São Paulo, Brazil and section editor of Cell Transplantation. "These promising results should be validated by a clinical study utilizing a larger cohort of patients as well as studies to help determine the reasons for the beneficial effect of the SV component."
-end-
Contact: Dr. Nicoletta Del Papa, UOC Day Hospital Reumatologia, Ospedale G. Pini, Via Pini, 9-20122 Milano, Italy
Email: delpapa@gpini.it
Tel: +39-0258296663
Fax: +39-025896495
Citation: Del Papa, N.; Di Luca, G.; Sambataro, D.; Zaccara, E.; Maglione, W.; Gabrielli, A.; Fraticelli, P.; Moroncini, G; Beretta, L.; Santaniello, A.; Sambataro, G.; Ferraresi, R.; Vitali, C. Regional implantation of autologous adipose tissue-derived cells induces a prompt healing of long-lasting indolent digital ulcers in patients with Systemic Sclerosis. Cell Transplant. Appeared or available on-line: December 12, 2014.

The Coeditors-in-chief for CELL TRANSPLANTATION are at the Diabetes Research Institute, University of Miami Miller School of Medicine and Center for Neuropsychiatry, China Medical University Hospital, TaiChung, Taiwan. Contact, Camillo Ricordi, MD at ricordi@miami.edu or Shinn-Zong Lin, MD, PhD at shinnzong@yahoo.com.tw or David Eve, PhD or Samantha Portis, MS, at celltransplantation@gmail.com

Cell Transplantation Center of Excellence for Aging and Brain Repair

Related Transplantation Articles from Brightsurf:

A revolutionary new treatment alternative to corneal transplantation
A new approach in ophthalmology that offers a revolutionary alternative to corneal transplantation has just been developed by researchers and clinicians in North America, Europe, and Oceania.

Fewer complications after organ transplantation
A large international study coordinated by University Hospital Regensburg and Charité - Universitätsmedizin Berlin has demonstrated the safety of new cell therapy approaches for use in kidney transplant recipients.

Elderly patients also benefit from kidney transplantation
So far, kidney transplantation has generally not been offered to elderly patients (>75 years) because of the perioperative risks.

New material will allow abandoning bone marrow transplantation
Scientists from the National University of Science and Technology 'MISIS' developed nanomaterial, which will be able to restore the internal structure of bones damaged due to osteoporosis and osteomyelitis.

Fewer medical tests -- timely listing for transplantation
Younger patients would benefit greatly from kidney transplantation. Their expected remaining lifetime may even be doubled by having a transplant.

Uterus transplantation -- ethically just as problematic as altruistic surrogacy
In 2014, the first child to have been gestated in a donated uterus was born.

Advancing transplantation: Hepatitis C-infected organs safe for transplantation when followed by antiviral treatment
Twenty patients at Penn Medicine have been cured of the hepatitis C virus (HCV) following lifesaving kidney transplants from deceased donors who were infected with the disease, according to a study published today in Annals of Internal Medicine.

Transplantation followed by antiviral therapy cured hepatitis C
Twenty patients who received kidneys transplanted from hepatitis C virus (HCV)-infected donors experienced HCV cure, good quality of life, and excellent renal function at one year.

The Journal of Heart and Lung Transplantation: 50 years of heart transplantation progress
This month marks the 50th anniversary of the world's first human heart transplant performed at Groote Schuur Hospital in Cape Town by South African surgeon, Christiaan Barnard.

Older donor lungs should be considered for transplantation
With a scarcity of lungs available for transplantation, the use of lungs from donors older than age 60 has been shown to achieve reasonable outcomes and should be considered as a viable option, according to research published online today in The Annals of Thoracic Surgery.

Read More: Transplantation News and Transplantation Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.